A Randomized, Open-Label Study to Compare the Safety and Efficacy of Cyclosporine Dose Reduction With Cyclosporine Elimination in De Novo Renal Allograft Recipients Receiving Rapamune.

Trial Profile

A Randomized, Open-Label Study to Compare the Safety and Efficacy of Cyclosporine Dose Reduction With Cyclosporine Elimination in De Novo Renal Allograft Recipients Receiving Rapamune.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2011

At a glance

  • Drugs Ciclosporin; Sirolimus
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 23 Jul 2007 Status change
    • 13 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top